Authors:
VISONNEAU S
CESANO A
TRAN T
JEGLUM KA
SANTOLI D
Citation: S. Visonneau et al., SUCCESSFUL TREATMENT OF CANINE MALIGNANT HISTIOCYTOSIS WITH THE HUMANMAJOR HISTOCOMPATIBILITY COMPLEX NONRESTRICTED CYTOTOXIC T-CELL LINE TALL-104, Clinical cancer research, 3(10), 1997, pp. 1789-1797
Authors:
CESANO A
VISONNEAU S
WOLFE JH
JEGLUM KA
FERNANDEZ J
GILLIO A
OREILLY RJ
SANTOLI D
Citation: A. Cesano et al., TOXICOLOGICAL AND IMMUNOLOGICAL EVALUATION OF THE MHC-NON-RESTRICTED CYTOTOXIC T-CELL LINE TALL-104, Cancer immunology and immunotherapy, 44(3), 1997, pp. 125-136
Citation: Rc. Rosenthal et Ka. Jeglum, CONTROVERSIES IN CLINICAL ONCOLOGY - PREFACE, The Veterinary clinics of North America. Small animal practice, 26(1), 1996, pp. 11-12
Citation: Ka. Jeglum, CHEMOIMMUNOTHERAPY OF CANINE LYMPHOMA WITH ADJUVANT CANINE MONOCLONAL-ANTIBODY-231, The Veterinary clinics of North America. Small animal practice, 26(1), 1996, pp. 73
Citation: Ka. Jeglum et K. Sadanaga, ORAL TUMORS - THE SURGEON AND THE MEDICAL ONCOLOGIST, The Veterinary clinics of North America. Small animal practice, 26(1), 1996, pp. 145
Authors:
CESANO A
VISONNEAU S
JEGLUM KA
OWEN J
WILKINSON K
CARNER K
REESE L
SANTOLI D
Citation: A. Cesano et al., PHASE-I CLINICAL-TRIAL WITH A HUMAN MAJOR HISTOCOMPATIBILITY COMPLEX NONRESTRICTED CYTOTOXIC T-CELL LINE (TALL-104) IN DOGS WITH ADVANCED TUMORS, Cancer research, 56(13), 1996, pp. 3021-3029
Authors:
FOX LE
MACEWEN EG
KURZMAN ID
DUBIELZIG RR
HEIFAND SC
VAIL DM
KISSEBERTH W
LONDON C
MADEWELL BR
RODRIGUEZ CO
JEGLUM KA
ROSENBERG M
ROSENTHAL RC
Citation: Le. Fox et al., LIPOSOME-ENCAPSULATED MURAMYL TRIPEPTIDE PHOSPHATIDYLETHANOLAMINE FORTHE TREATMENT OF FELINE MAMMARY ADENOCARCINOMA - A MULTICENTER RANDOMIZED DOUBLE-BLIND-STUDY (VOL 10, PG 125, 1995), Cancer biotherapy, 10(3), 1995, pp. 249-249
Authors:
FOX LE
MACEWEN EG
KURZMAN ID
DUBIELZIG RR
HELFAND SC
VAIL DM
KISSEBERTH W
LONDON C
MADEWELL BR
RODRIGUEZ CO
JEGLUM KA
ROSENBERG M
ROSENTHAL RC
Citation: Le. Fox et al., LIPOSOME-ENCAPSULATED MURAMYL TRIPEPTIDE PHOSPHATIDYLETHANOLAMINE FORTHE TREATMENT OF FELINE MAMMARY ADENOCARCINOMA - A MULTICENTER RANDOMIZED DOUBLE-BLIND-STUDY, Cancer biotherapy, 10(2), 1995, pp. 125-130
Authors:
HELFAND SC
HAMILTON TA
HUNGERFORD LL
JEGLUM KA
GOLDSCHMIDT MA
Citation: Sc. Helfand et al., COMPARISON OF 3 TREATMENTS FOR TRANSITIONAL-CELL CARCINOMA OF THE BLADDER IN THE DOG, The Journal of the American Animal Hospital Association, 30(3), 1994, pp. 270-275
Citation: Cg. Kilrain et al., MALIGNANT ANGIOENDOTHELIOMATOSIS WITH RETINAL DETACHMENTS IN A DOG, Journal of the American Veterinary Medical Association, 204(6), 1994, pp. 918-921
Citation: Ku. Sorenmo et al., CHEMOTHERAPY OF CANINE HEMANGIOSARCOMA WITH DOXORUBICIN AND CYCLOPHOSPHAMIDE, Journal of veterinary internal medicine, 7(6), 1993, pp. 370-376